IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial Supply Disruption — Fresenius Kabi USA LLC (FK US
IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial Supply Disruption — Fresenius Kabi USA LLC (FK US is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial; Manufacturer: Frese
| Drug name | IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial |
|---|---|
| Manufacturer | Fresenius Kabi USA LLC (FK USA) |
| Recall/Disruption reason | Crystallization: Active pharmaceutical ingredient is precipitating in product solution. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-915-2013 |
| Initiation date | 20130122 |
| Quantity affected | 23,672 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →